Articles

North American Survey of Laboratory Purchasing Trends

Results provide a snapshot of how laboratories across North America are planning to spend for equipment, staffing and facilities in 2015
Written byJeffrey Bouley
| 3 min read

WASHINGTON, D.C.—As has become a tradition at the annual meeting of the Society for Laboratory Automation and Screening (SLAS), K.C. Warawa provided her overview of the North American Survey of Laboratory Purchasing Trends, an effort that is a partnership between SLAS and the Laboratory Products Association (LPA). The annual meeting was the first presentation of this year’s annual report, which shows how laboratories across North America are planning to spend for equipment, staffing and facilities in 2015.

As SLAS notes, the survey allows laboratory managers and personnel “Understand the priority concerns of other laboratory professionals and management to make sure you and your organization are prepared.”

To continue reading this article, subscribe for FREE toDrug Discovery News Logo

Subscribe today to keep up to date with the latest advancements and discoveries in drug development achieved by scientists in pharma, biotech, non-profit, academic, clinical, and government labs.

Add Drug Discovery News as a preferred source on Google

Add Drug Discovery News as a preferred Google source to see more of our trusted coverage.

About the Author

Here are some related topics that may interest you:

Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

Illustration of multiple three-dimensional patient-derived organoids suspended against a dark blue background, representing tumor models used in precision oncology research.
By combining organoid biology with precision automation, researchers developed a miniaturized organoid screening platform that could help speed personalized cancer treatment testing.
Illustration of multiple three-dimensional patient-derived organoids suspended against a dark blue background, representing tumor models used in precision oncology research.
By combining organoid biology with precision automation, researchers developed a miniaturized organoid screening platform that could help speed personalized cancer treatment testing.
3D illustration of a membrane protein embedded within a lipid nanodisc, representing a native-like environment used for membrane protein stabilization and characterization.
Mass photometry supports membrane protein characterization by providing rapid insights into sample composition, purity, and molecular assembly.
Drug Discovery News December 2025 Issue
Latest IssueVolume 21 • Issue 4 • December 2025

December 2025

December 2025 Issue

Explore this issue